The veterinary active pharmaceutical ingredient (API) market in terms of revenue was estimated to be worth $5.2B in 2023 and is poised to reach $7.1B by 2028, growing at a CAGR of 6.5% from 2023 to 2028, according to a report by MarketsandMarkets™. The market for veterinary API is expanding because of factors like rising incidence of transboundary & zoonotic diseases, increasing animal population and pet ownership, and increasing disease control & disease prevention measures. The veterinary API industry is anticipated to develop because of the rising demand for veterinary medicines and other animal health products.
The veterinary API industry is poised for significant growth in the near future. As pet ownership continues to rise and people's awareness of animal health and welfare deepens, the demand for veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) is expected to skyrocket. With advancements in technology and research, the industry is likely to witness the development of innovative APIs that are more efficient and tailored to specific animal species, ensuring optimal therapeutic outcomes. Additionally, there is a growing focus on the use of natural and herbal APIs, reflecting the increasing preference for holistic and alternative veterinary treatments. Furthermore, the integration of digital solutions, such as telemedicine and remote monitoring, will revolutionize veterinary care, enabling accurate diagnosis, personalized treatment plans, and enhanced overall healthcare for animals. The veterinary API industry, driven by these transformative trends, is set to make significant strides in improving animal health and well-being in the near future.